P085: GSD1 subtype 1B: Timeline and progression of clinical symptoms in a patient with juvenile idiopathic arthritis

She was managed on corn starch every 4 h until 2 years of age. At age of 2, she started with long-acting maize-based starch at bedtime to improve sleep. She had recurrent bacterial infections: gingivitis, mastoiditis, and recurrent oral ulcers, each of which required hospital admission for antibiotics and GCSF. She also required admissions for management of hypoglycemia. She contracted MISC-COVID in 2020, requiring GCSF, intravenous immunoglobulin, and packed red blood cells to treat anemia. At age 7, she was started on SGLT-2 inhibitor and has been on it for almost 3 years.